Use of Dynamic Arm Supports to Promote Activities of Daily Living in Individuals With DMD
NCT03531788 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2022-02-18
Summary
This study is a longitudinal, randomized control trial evaluating the use of two commercially available dynamic arm support devices (1) Armon Ayura-Kinova and 2) JAECO WREX) to promote participation in activities of daily living (ADLs) in non-ambulatory individuals with Duchenne muscular dystrophy (DMD) with upper extremity weakness.
Conditions
Interventions
- DEVICE
-
Armon Ayura (Kinova)
Actively assisted mechanical arm support (electric powered to balance arm)
- DEVICE
-
JAECO Wrex
Passive mechanical arm support (elastic bands to balance arm)
Sponsors & Collaborators
-
Roxanna Marie Bendixen
lead OTHER
Principal Investigators
-
Roxanna M Bendixen, PhD · University of Pittsburgh
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 14 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-30
- Primary Completion
- 2020-12-31
- Completion
- 2020-12-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD)
NCT02579239 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Natural History Study In Chinese Male Patients With Duchenne Muscular Dystrophy
NCT03760029 ·Status: COMPLETED ·Phase: NA
-
Technology Assisted Rehabilitation for Upper Limb Function in Myotonic Dystrophy Type 1
NCT05560438 ·Status: COMPLETED ·Phase: NA
-
Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy
NCT03179631 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy
NCT02310763 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy
NCT03400852 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Intramuscular Gene Transfer Trial of rAAVrh74.MCK.Micro-Dystrophin to Patients With Duchenne Muscular Dystrophy
NCT02376816 ·Status: COMPLETED ·Phase: PHASE1
-
Strength Training in Duchenne Muscular Dystrophy
NCT02421523 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
NCT01462292 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
NCT03038399 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Participants With Muscular Dystrophy
NCT02239224 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Low-level Mechanical Vibration on Bone Density in Ambulant Children Affected by Duchenne Muscular Dystrophy
NCT05281120 ·Status: COMPLETED ·Phase: NA
-
Duchenne Muscular Dystrophy Clinical Trial
NCT01874275 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
NCT02760264 ·Status: COMPLETED ·Phase: PHASE2
-
Biomechanical Analysis of Gait in Individuals With Duchenne Muscular Dystrophy
NCT00312247 ·Status: COMPLETED
-
Study of Ataluren (PTC124) in Nonambulatory Participants With Nonsense-Mutation-Mediated Duchenne/Becker Muscular Dystrophy (nmDMD/BMD)
NCT01009294 ·Status: TERMINATED ·Phase: PHASE2
-
Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD
NCT02515669 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy
NCT02354781 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular Dystrophy
NCT00243789 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Gene Transfer Clinical Trial to Deliver rAAVrh74.MCK.GALGT2 for Duchenne Muscular Dystrophy
NCT03333590 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pentoxifylline in Duchenne Muscular Dystrophy
NCT00102453 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD)
NCT04371666 ·Status: TERMINATED ·Phase: PHASE3
-
Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy
NCT03039686 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Ataluren in ≥2 to <5 Year-Old Male Participants With Duchenne Muscular Dystrophy
NCT02819557 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability of WVE-210201 in Patients With Duchenne Muscular Dystrophy
NCT03508947 ·Status: COMPLETED ·Phase: PHASE1